Vaccine comprising fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus
US5403582A · kind A · utility
21Cited by
3References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 21, 1993 |
| Grant date | Apr 4, 1995 |
| Priority date | — |
| Expiry date | Jan 21, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/11022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A recombinant fowlpox virus is provided which is useful as a vaccine for protection against avian reticuloendo-theliosis virus-associated diseases. In a specific embodiment, the recombinant virus expresses a gene encoding an envelope glycoprotein of spleen necrosis virus under the control of a poxvirus promoter, inserted in a nonessential region of the fowlpox virus genome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.